Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to Committee

Meet the Program Commitee for 2023!

Program Committee

  • Claudia   Ferreira
    Claudia Ferreira Scientific Programmes Specialist
    DIA, Switzerland
  • Sara  Torgal, MPharm
    Sara Torgal, MPharm Senior Manager, Scientific Programs
    DIA, Switzerland
  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Karl  Broich, DrMed
    Karl Broich, DrMed President
    Federal Institute for Drugs and Medical Devices (BfArM), Germany
  • Natasha  Jarrett
    Natasha Jarrett Head Immunology, Infectious Disease, Ophthalmology, Neuroscience, Regulatory
    F. Hoffmann-La Roche Ltd., Switzerland
  • Indranil  Bagchi, PhD, MSc
    Indranil Bagchi, PhD, MSc Global Head, Pricing & Market Access
    GSK, United States
  • Jan  Geissler, MBA
    Jan Geissler, MBA Managing Director
    Patvocates, Germany
  • Magda  Chlebus, MA
    Magda Chlebus, MA Executive Director, Science Policy & Regulatory Affairs
    EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
  • Anja  Schiel, PhD
    Anja Schiel, PhD Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA
    Norwegian Medicines Agency (NoMA), Norway
  • Ian  Hudson
    Ian Hudson Senior Advisor, Integrated Development
    Bill and Melinda Gates Foundation, United States
  • Patrick  Brady, PharmD
    Patrick Brady, PharmD Global Head, Therapeutic Innovation & Regulatory Science
    IQVIA, United States
  • Thomas  Brookland, MSc
    Thomas Brookland, MSc EU Data and AI Policy Lead
    F. Hoffmann-La Roche Ltd, Switzerland
  • Jesper  Kjær, MS
    Jesper Kjær, MS Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs
    Novo Nordisk, Denmark
  • Thomas  Schindler, PhD
    Thomas Schindler, PhD Director Global Regulatory Affairs - Regulatory Operations
    BioNTech SE, Germany
  • Derek   Johnston
    Derek Johnston QA Director, Regulatory Intelligence Office
    Labcorp Drug Development, United Kingdom
  • Lucia  D'Apote, DrSc, RAC
    Lucia D'Apote, DrSc, RAC Executive Director Global Regulatory and R&D Policy (ELMAC and JAPAC)
    Amgen, Switzerland
  • Ursula  Busse, PhD, MBA
    Ursula Busse, PhD, MBA Head of Regulatory Affairs
    Tigen Pharma SA, Switzerland
  • Markus  Goese
    Markus Goese Head EU CMC Regulatory Policy
    F. Hoffmann-La Roche Ltd, Switzerland
  • Claudia  Hey, DrSc, PharmD
    Claudia Hey, DrSc, PharmD Senior Director, Head Europe Global Regulatory & Scientific Policy
    Merck Healthcare KGaA, Germany
  • Laura  Oliveira
    Laura Oliveira Regulatory Affairs, Director
    MSD Spain , Spain
  • Bjorg  Hunter, MSc
    Bjorg Hunter, MSc Director
    Novo Nordisk, Denmark
  • Tim  Chesworth
    Tim Chesworth Senior Director Regulatory Affairs
    AstraZeneca, United Kingdom
  • Francoise  Sillan, MD
    Francoise Sillan, MD EU1 UK QPPV
    Ipsen, France
  • Phil  Tregunno
    Phil Tregunno Deputy Director - Patient Safety Monitoring
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Sina  Schader, DrMed
    Sina Schader, DrMed Head of QPPV Office and EU QPPV
    AbbVie, Germany
  • Susanne  Ausborn, PhD
    Susanne Ausborn, PhD Global Head International Regulatory Policy
    Roche, Switzerland
  • Rodrigo  Palacios, MBA
    Rodrigo Palacios, MBA Regulatory Policy Lead
    F. Hoffmann-La Roche, Switzerland
  • Ronnie Harprit Mundair
    Ronnie Harprit Mundair Regional Labelling Head - AfME, Canada and LATAM - Senior Director
    Pfizer, United Kingdom
  • Edith  Frénoy, MA, MSc
    Edith Frénoy, MA, MSc Director, European Public Policy – Strategic EU Advocacy Lead
    MSD Europe Inc., Belgium
  • Wija  Oortwijn, PhD, MSc
    Wija Oortwijn, PhD, MSc Senior Scientific Researcher, Department for Health Evidence
    Radboud University Medical Centre, Netherlands
  • Aleksandar  Ruzicic
    Aleksandar Ruzicic Chairman and CEO
    Almasan AG, Switzerland
  • Youness  Ameur
    Youness Ameur Regulatory Associate Program Director
    Roche, Switzerland
  • Jelena   Duza
    Jelena Duza Junior Public Affairs Manager
    Novartis, Switzerland
  • Elena  Popa, MPharm
    Elena Popa, MPharm Regulatory Policy and Innovation Lead
    Bayer, Switzerland
  • Theo  Favard
    Theo Favard Vice President of External Relations
    European Pharmaceutical Students' Association (EPSA), Belgium
  • Francisca  Vaz
    Francisca Vaz Senior Specialist, QA Release Coordinator,
    Moderna, Switzerland
Load More

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.